We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+1.41%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$712M
AUM Growth
+$710M
Cap. Flow
-$649M
Cap. Flow %
-91.27%
Top 10 Hldgs %
6.85%
Holding
408
New
37
Increased
7
Reduced
332
Closed
32

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$9.58M
2
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$2M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.96M
4
SIG icon
Signet Jewelers
SIG
+$1.34M
5
YHOO
Yahoo Inc
YHOO
+$1.29M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$14.4M
2
MSFT icon
Microsoft
MSFT
+$7.81M
3
AAPL icon
Apple
AAPL
+$6.72M
4
GILD icon
Gilead Sciences
GILD
+$5.41M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$5.38M

Sector Composition

Rank Sector Weight
1 Technology 14.08%
2 Financials 13.4%
3 Healthcare 12.23%
4 Consumer Discretionary 11%
5 Industrials 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGNX icon
301
MacroGenics
MGNX
$257M
$742K 0.1%
27,483
-18,259
-40% -$412K
V icon
302
Visa
V
$677B
$741K 0.1%
8,136
-48,292
-86% -$3.78M
ATRA icon
303
Atara Biotherapeutics
ATRA
$76.1M
$740K 0.1%
1,315
-372
-22% -$179K
HCA icon
304
HCA Healthcare
HCA
$89.5B
$739K 0.1%
+9,594
New +$757K
TDG icon
305
TransDigm Group
TDG
$67.7B
$739K 0.1%
2,264
-6,426
-74% -$1.57M
UHS icon
306
Universal Health Services
UHS
$10.5B
$734K 0.1%
+5,477
New +$722K
PG icon
307
Procter & Gamble
PG
$339B
$732K 0.1%
8,650
-17,886
-67% -$1.47M
LH icon
308
Labcorp
LH
$25.9B
$731K 0.1%
+6,536
New +$703K
BMY icon
309
Bristol-Myers Squibb
BMY
$132B
$730K 0.1%
9,926
-44,306
-82% -$3.13M
NVS icon
310
Novartis
NVS
$297B
$730K 0.1%
9,880
-11,168
-53% -$772K
SHW icon
311
Sherwin-Williams
SHW
$89.8B
$725K 0.1%
+5,988
New +$583K
BLUE
312
DELISTED
bluebird bio
BLUE
$722K 0.1%
1,287
-484
-27% -$274K
ROST icon
313
Ross Stores
ROST
$81.9B
$718K 0.1%
12,664
-23,246
-65% -$1.29M
LUMO
314
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$710K 0.1%
7,005
+2,617
+60% +$324K
ABMD
315
DELISTED
Abiomed Inc
ABMD
$708K 0.1%
6,476
-18,464
-74% -$1.84M
HUM icon
316
Humana
HUM
$46.2B
$703K 0.1%
3,910
-7,272
-65% -$1.29M
BLCM
317
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$701K 0.1%
5,407
-2,167
-29% -$241K
MDT icon
318
Medtronic
MDT
$112B
$697K 0.1%
8,033
-19,769
-71% -$1.6M
IOVA icon
319
Iovance Biotherapeutics
IOVA
$2.83B
$694K 0.1%
85,707
-91,013
-52% -$572K
PNC icon
320
PNC Financial Services
PNC
$101B
$694K 0.1%
8,529
-9,037
-51% -$777K
CTMX icon
321
CytomX Therapeutics
CTMX
$753M
$692K 0.1%
67,721
-6,109
-8% -$69.7K
JCI icon
322
Johnson Controls International
JCI
$92.2B
$687K 0.1%
+14,824
New +$653K
FPRX
323
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$687K 0.1%
16,615
-18,681
-53% -$813K
LLY icon
324
Eli Lilly
LLY
$1.06T
$685K 0.1%
8,704
-19,656
-69% -$1.48M
WEB
325
DELISTED
Web.com Group, Inc.
WEB
$685K 0.1%
+37,704
New +$686K
11 12
13
14 15

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q2 2016 Portfolio in Review

As of Q2 2016, Vident Investment Advisory held 408 positions worth $712M, up 43,807% from $1.62M the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.

Vident Investment Advisory withdrew a net $649M in Q2 2016, closing 32 positions and reducing 332 holdings. Its most notable exit was Allergan plc, an estimated $11.2K position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Vident Investment Advisory opened a new position in State Street SPDR S&P 500 ETF Trust worth $9.68M.

  • Vident Investment Advisory's largest Q2 2016 buy was State Street SPDR S&P 500 ETF Trust: 46,190 shares worth $9.68M.
  • Vident Investment Advisory added most to Meta Platforms (Facebook) in Q2 2016, an estimated $1.05M increase.
  • Vident Investment Advisory's biggest Q2 2016 reduction was Amazon, cutting an estimated $14.4M.
  • Vident Investment Advisory fully exited Allergan plc in Q2 2016, selling an estimated $11.2K.
  • Vident Investment Advisory's ten largest holdings make up 6.9% of its $712M portfolio in Q2 2016.
  • Vident Investment Advisory opened 37 new positions and closed 32 in Q2 2016.
  • Vident Investment Advisory's portfolio value rose 43,807% quarter-over-quarter to $712M.

Based on Vident Investment Advisory's 13F filing for Q2 2016, filed 12 Aug 2016.